Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 8c

Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 9, 2021 4:39 PM EDT

-Q2 2021 Total Net Revenues of $36.4 Million Reflect Strong Quarter over Quarter Growth

-Q2 2021 GAAP Net Income of $12.2 Million; Non-GAAP Net Income of $17.4 Million

-$155.3 Million in Cash and Investments and no Funded Debt at End of Q2-2021

-Catalyst to Host Quarterly Conference Call at 8:30 AM ET Tomorrow

CORAL GABLES, Fla., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines... More